Mel Sorensen - President and CEO, Director at Galera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
GRTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mel Sorensen since 7/7/2023

Holdings reported by Mel Sorensen for Galera Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 332,044 $746 K $2.25 Mar 10, 2023 Direct
Stock Option (Right to Buy) 440,000 Feb 25, 2023 Direct Common Stock

Transactions reported by Mel Sorensen for Galera Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership